People who have experienced brain injuries could benefit from an alternative medicine, academics in the US have found.
A medication known as levetiracetam, which is marketed as Keppra, was as effective at preventing seizures as the traditional medicine phenytoin, marketed as Dilantin, according to the study that will be published in the April issue of the journal Neurocritical Care.
The research, which was carried out by scientists at the University of Cincinnati Neuroscience Institute (UCNI), also discovered that the alternative medicine led to few side effects.
Co-investigator Dr Jerzy Szaflarski, associate professor of neurology at UCNI, explained why this type of medication can be beneficial for brain injury patients: "Preventing seizures is a critical part of protecting a patient's brain from further injury following trauma or stroke."
Meanwhile, biopharmaceutical firm Moleac has said that data published in the journal Neuropharmacology shows its medicine NeuroAID had positive effects on neuronal and brain injuries, as well as in the recovery of neurological functions.
News brought to you by Serious Law specialists in brain injury